Current year alerts The following alerts have been issued by the TGA in the current year. Existing web page () All alerts The following alerts about therapeutic products have been issued by the TGA since 1998. This list is also available in date order: | | | | | | | | | | | | | | | | | | | | | | | | | | | Existing web page () About alerts The TGA issues alerts to advise consumers, health professionals and industry new safety information regarding therapeutic products. An alert does not necessarily mean that a product is considered to be unsafe. Alerts may explain the outcome of an investigation including any recommended actions for consumers and health professionals or a change to the availability of a product, or may advise that counterfeit or illegal products have been detected in Australia. New web page ( TBA) Monitoring communications The TGA emphasises that patients should NOT stop using a medicine or medical device subject to a monitoring communication. If you have any concerns with a therapeutic product you are using, please contact your health professional. A monitoring communication highlights potential safety concerns identified by the TGA with a therapeutic product. The appearance of a safety concern in this section does not mean that the TGA has concluded that the medicine or medical device causes an adverse event. All monitoring communications issued will have a subsequent communication advising of the outcome. Links to monitoring communications issued by the TGA during the current year Links to monitoring communications issued by the TGA since 2013 Monitoring communications highlight potential safety concerns identified by the TGA with therapeutic goods
Current year alerts The following alerts have been issued by the TGA in the current year. Existing web page () All alerts The following alerts about therapeutic products have been issued by the TGA since 1998. This list is also available in date order: | | | | | | | | | | | | | | | | | | | | | | | | | | | Existing web page () About alerts The TGA issues alerts to advise consumers, health professionals and industry new safety information regarding therapeutic products. An alert does not necessarily mean that a product is considered to be unsafe. Alerts may explain the outcome of an investigation including any recommended actions for consumers and health professionals or a change to the availability of a product, or may advise that counterfeit or illegal products have been detected in Australia. New web page ( TBA) Monitoring communications The TGA emphasises that patients should NOT stop using a medicine or medical device subject to a monitoring communication. If you have any concerns with a therapeutic product you are using, please contact your health professional. A monitoring communication highlights potential safety concerns identified by the TGA with a therapeutic product. The appearance of a safety concern in this section does not mean that the TGA has concluded that the medicine or medical device causes an adverse event. All monitoring communications issued will have a subsequent communication advising of the outcome. Links to monitoring communications issued by the TGA during the current year Links to monitoring communications issued by the TGA since 2013 Monitoring communications highlight potential safety concerns identified by the TGA with therapeutic goods
consult-anztpa-early-warning-system-130308-1_0.docx